Agios Pharmaceuticals (AGIO)
$37.49
0.25 (0.67%)
AGIO Stock Quote Delayed 20 Minutes
Previous Close
$37.49
Market Cap
2.16B
PE Ratio
-5.50
EPS
-6.82
Volume (Avg. Vol.)
714,900
Day's Range
36.00 - 38.44
52-Week Range
27.77 - 68.85
Dividend & Yield
N/A (N/A)
AGIO Stock Predictions, Articles, and Agios Pharmaceuticals News
Agios Pharmaceuticals, Inc.Stock Is an Analyst Darling for Good Reason
Celgene buying out Agios would make sense but either way the company's work on cellular metabolism and gene deleting is interesting the bulls the most. Agios stock is a good buy on its own merits.
Liberty Sirius XM Group (LSXMK) Lead 12 Activist Investor Reports
Recent 13-D and 13-G filings are windows into activist investors activity. We look at Liberty Sirius XM Group and 11 others
40 Biotechnology Stocks to Sell Now
This week, the overall grades of 40 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
40 Biotechnology Stocks to Sell Now
The overall ratings of 40 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Why Agios Pharmaceuticals Inc (AGIO), LPL Financial Holdings Inc (LPLA) and Humana Inc (HUM) Are 3 of Today’s Worst Stocks
Agios (AGIO), LPL Financial (LPLA) and Humana (HUM) were wishing the weekend could have lasted one more day on Monday.
22 Biotechnology Stocks to Sell Now
This week, 22 Biotechnology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
3 Stocks With Plunging Prices
Here's why Agios Pharmaceuticals Inc (AGIO), Zulily Inc (ZU) and Aruba Networks, Inc. (ARUN) are three of today's worst stocks.
11 Biotechnology Stocks to Buy Now
This week, 11 biotechnology stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
9 Biotechnology Stocks to Buy Now
This week, nine biotechnology stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
8 Biotechnology Stocks to Buy Now
The grades of eight biotechnology stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
25 Small-Cap Stocks to Buy
This list of 25 small-cap stocks to buy includes some tech stocks and consumer plays that could add 25% in the next year.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
D
